Atlas Trials

Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

Clinical trial NCT04935853 · RECRUITING

Trial details

NCT number
NCT04935853
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
RECRUITING
Study type
OBSERVATIONAL
Biliary Tract Cancer
Start date
2022-05-23
Primary completion
2030-06-01
Enrollment
1350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.